These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10898571)

  • 1. Transglutaminase-mediated dual and site-specific incorporation of poly(ethylene glycol) derivatives into a chimeric interleukin-2.
    Sato H; Yamamoto K; Hayashi E; Takahara Y
    Bioconjug Chem; 2000; 11(4):502-9. PubMed ID: 10898571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic procedure for site-specific pegylation of proteins.
    Sato H
    Adv Drug Deliv Rev; 2002 Jun; 54(4):487-504. PubMed ID: 12052711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the site-specific protein modification by microbial transglutaminase.
    Sato H; Hayashi E; Yamada N; Yatagai M; Takahara Y
    Bioconjug Chem; 2001; 12(5):701-10. PubMed ID: 11562188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific modification of interleukin-2 by the combined use of genetic engineering techniques and transglutaminase.
    Sato H; Ikeda M; Suzuki K; Hirayama K
    Biochemistry; 1996 Oct; 35(40):13072-80. PubMed ID: 8855943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues.
    Spolaore B; Raboni S; Satwekar AA; Grigoletto A; Mero A; Montagner IM; Rosato A; Pasut G; Fontana A
    Bioconjug Chem; 2016 Nov; 27(11):2695-2706. PubMed ID: 27731976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s.
    Shimada K; Kamps JA; Regts J; Ikeda K; Shiozawa T; Hirota S; Scherphof GL
    Biochim Biophys Acta; 1997 Jun; 1326(2):329-41. PubMed ID: 9218563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique substrate specificities of two adjacent glutamine residues in EAQQIVM for transglutaminase: identification and characterization of the reaction products by electrospray ionization tandem mass spectrometry.
    Sato H; Yamada N; Shimba N; Takahara Y
    Anal Biochem; 2000 May; 281(1):68-76. PubMed ID: 10847612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
    Mero A; Spolaore B; Veronese FM; Fontana A
    Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific derivatization of avidin using microbial transglutaminase.
    Spolaore B; Damiano N; Raboni S; Fontana A
    Bioconjug Chem; 2014 Mar; 25(3):470-80. PubMed ID: 24517223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of transglutaminase substrate peptides for rapid enzymatic formation of hydrogels.
    Hu BH; Messersmith PB
    J Am Chem Soc; 2003 Nov; 125(47):14298-9. PubMed ID: 14624577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
    Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
    Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificities of microbial transglutaminase for primary amines.
    Ohtsuka T; Sawa A; Kawabata R; Nio N; Motoki M
    J Agric Food Chem; 2000 Dec; 48(12):6230-3. PubMed ID: 11141280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed pegylation of recombinant interleukin-2 at its glycosylation site.
    Goodson RJ; Katre NV
    Biotechnology (N Y); 1990 Apr; 8(4):343-6. PubMed ID: 1366535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New fluorescent substrates of microbial transglutaminase and its application to peptide tag-directed covalent protein labeling.
    Kamiya N; Abe H
    Methods Mol Biol; 2011; 751():81-94. PubMed ID: 21674327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule dependency of the antitumor activity and toxicity of polyethylene glycol-modified interleukin 2 in murine tumor models.
    Zimmerman RJ; Aukerman SL; Katre NV; Winkelhake JL; Young JD
    Cancer Res; 1989 Dec; 49(23):6521-8. PubMed ID: 2819708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local unfolding is required for the site-specific protein modification by transglutaminase.
    Spolaore B; Raboni S; Ramos Molina A; Satwekar A; Damiano N; Fontana A
    Biochemistry; 2012 Oct; 51(43):8679-89. PubMed ID: 23083324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates.
    Case A; Stein RL
    Biochemistry; 2003 Aug; 42(31):9466-81. PubMed ID: 12899634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins.
    Gaertner HF; Offord RE
    Bioconjug Chem; 1996; 7(1):38-44. PubMed ID: 8741989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.